
Chemical and Pharmaceutical Bulletin p. 1412 - 1414 (1996)
Update date:2022-09-26
Topics:
Satoh, Masato
Okamoto, Yoshinori
Koshio, Hiroyuki
Ohta, Mitsuaki
Nishida, Akito
Akuzawa, Shinobu
Miyata, Keiji
Mase, Toshiyasu
Semple, Graeme
A series of (3-substituted phenyl)urea analogues of the potent gastrin/cholecystokinin (CCK)-B receptor antagonist YM022 has been prepared. Structure activity relationship studies of this series suggested that a number of analogues retained good in vitro potency for gastrin/CCK-B receptor. In particular, the (3-amino substituted phenyl)urea derivatives (10-12) were more potent inhibitors of pentagastrin-induced gastric acid secretion in rats than YM022 on intraduodenal (i.d.) administration.
View MoreContact:0086 533 2282832
Address:Zibo,Shandong
Shanghai Yuanye Bio-Technology Co., Ltd.
website:http://www.shyuanye.com
Contact:+86-21-61845781
Address:Building 6, No. 465, Changta Road,Songjiang District,Shanghai,China
Contact:0086-27-83607103/83642615
Address:No.498, Jianshe Ave, Wuhan, China
HUNAN CHEMAPI BIOLOGICAL TECHNOLOGY CO.,LTD.
Contact:+86-186-02659358
Address:1004, building 3, Wanke Jinsemaitianyuan, 498 Guitang Road, Yuhua District, Changsha City, Hunan Province, China
Synchem Pharma Co.,Ltd(expird)
Contact:+0086-21-61984905-1
Address:Building 60,Zimian Park, LongYang industrial Area, 1515Nong,Yuandong Road Fengxian District, Shanghai ,China
Doi:10.1016/S0957-4166(03)00483-X
(2003)Doi:10.1055/s-2006-944222
(2006)Doi:10.1023/A:1023931428206
(2003)Doi:10.1055/s-1976-24162
(1976)Doi:10.1021/ja00439a074
(1976)Doi:10.1021/jo00427a031
(1977)